Open AccessSodium ferric gluconate complex in haemodialysis patients: a prospective evaluation of long-term safety
Author(s) -
B. Michael,
Daniel W. Coyne,
Vaughn W. Folkert,
Naomi V. Dahl,
David G. Warnock
Publication year - 2004
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfh222
Subject(s) - medicine , term (time) , prospective cohort study , hemodialysis , intensive care medicine , sodium , surgery , urology , metallurgy , physics , materials science , quantum mechanics
A previous single dose placebo-controlled double-blinded trial showed an extremely low (0.4%) intolerance rate of sodium ferric gluconate complex (SFGC) in SFGC-naive haemodialysis patients. No large prospective trials have assessed the safety of SFGC during repeated exposure in the outpatient haemodialysis setting.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom